Atlas Trials

Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Clinical trial NCT07776080 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07776080
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
HCC - Hepatocellular Carcinoma
Start date
2026-10-01
Primary completion
2027-10-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.